Resources
-
Communicating Issues with Capillary Electrophoresis Methods to Management, QA, and Regulatory [Session 2]
Roundtable Notes: Session 2 Table 2 CE Pharm 2025
Communicating Issues with Capillary Electrophoresis Methods to Management, QA, and Regulatory -
Communicating Issues with Capillary Electrophoresis Methods to Management, QA, and Regulatory
Roundtable Notes: Session 1 Table 2 CE Pharm 2025
Communicating Issues with Capillary Electrophoresis Methods to Management, QA, and Regulatory -
CE-MS - Current Trends and Applications in Biopharmaceutical Development [Session 2]
Roundtable Notes: Session 2 Table 3 CE Pharm 2025
CE-MS - Current Trends and Applications in Biopharmaceutical Development -
CE-MS - Current Trends and Applications in Biopharmaceutical Development
Roundtable Notes: Session 1 Table 3 CE Pharm 2025
CE-MS - Current Trends and Applications in Biopharmaceutical Development -
Becoming the CE Expert in Your Organization – Best Practices Exchange
Roundtable Notes: Session 2 Table 9 CE Pharm 2025
Becoming the CE Expert in Your Organization – Best Practices Exchange -
CE Pharm 2025 Summary Infographic
Summary Infographic: CE Pharm 2025
-
CE Pharm 2025 Scientific Program
Scientific Program: CE Pharm 2025
-
Advancing Targeted LNP Platforms
Speaker Presentation: Consultants' Network September 2025
Lemercier Jean-Noel, Editas Medicine, Inc., 2025 -
CMC Strategy Forum Latin America 2025 Scientific Program
Scientific Program: CMC Strategy Forum Latin America 2025
-
Reliance as an Essential Tool to Promote Efficient and Robust Global Regulatory Oversight
Speaker Presentation: CMC Strategy Forum Latin America 2025
Valentin Marie, World Health Organization, 2025 -
Navigating Complexity: PGMP Implementation for Sterile Medicines During the Pandemic
Speaker Presentation: CMC Strategy Forum Latin America 2025
Pompeu Beatriz, Batista Fernanda, European Medicines Agency (EMA), 2025 -
International Cooperation and Reliance in Practice
Speaker Presentation: CMC Strategy Forum Latin America 2025
Harvey Martin, European Medicines Agency (EMA), 2025 -
Development of ICH M4Q(R2) Common Technical Document on Quality - Guideline Update
Speaker Presentation: CMC Strategy Forum Latin America 2025
Hamel Hugo, Health Canada, 2025 -
Roche’s Second EMA WHO PAC Reliance Project
Speaker Presentation: CMC Strategy Forum Latin America 2025
Espinola Victoria, Roche International Ltd., 2025 -
Biologic Product Review Through Reliance: A Chilean Pilot
Speaker Presentation: CMC Strategy Forum Latin America 2025
Bori Francisco, Public Health Institute of Chile (ISPCH), 2025 -
Bridging Innovation and Access: Advancing Regulatory Capacity and AI-Driven Drug Development
Speaker Presentation: CMC Strategy Forum Latin America 2025
Auclair Jared, Northeastern University, 2025 -
Innovative Digital Regulatory Transformation: The First Cloud-based Submission
Speaker Presentation: CMC Strategy Forum Latin America 2025
Abernathy Michael, Amgen Inc., 2025 -
Best Practices for In-Use Stability and Compatibility Studies
Summary Papers: CMC Strategy Forum North America 2024
-
“Catch Me if You Can” Analytical Considerations for the Control of Multi-Specific Antibody (MsAb) Homodimer Impurities
Speaker Presentation: CMC Strategy Forum North America 2025
Zhang Fang, Pfizer, Inc., 2025 -
Navigating the Regulatory Landscape for Multispecifics & Bioconjugates
Speaker Presentation: CMC Strategy Forum North America 2025
Yeung Angela, Health Canada, 2025